Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Susan Baldwin
Introduction
Susan Baldwin is a notable inventor based in Seattle, Washington. She has made significant contributions to the field of immunology through her innovative work on adjuvant formulations. Her research focuses on enhancing immune responses, which is crucial for the development of effective vaccines and pharmaceutical compositions.
Latest Patents
Susan Baldwin holds a patent titled "Adjuvant formulations comprising TLR4 agonists and methods of using the same." This patent discloses formulations and methods, including vaccines and pharmaceutical compositions, designed to induce or enhance an immune response. The formulations generally comprise a TLR4 agonist and a metabolizable oil at a concentration of about 0.01%-1% v/v, wherein the hydrophobic:lipophilic balance (HLB) of the emulsion is greater than about 9.
Career Highlights
Throughout her career, Susan has worked with various organizations that focus on health and disease research. Notably, she has been associated with Access to Advanced Health Institute and the Infectious Disease Research Institute. Her work in these institutions has allowed her to contribute to advancements in health and immunology.
Collaborations
Susan Baldwin has collaborated with esteemed colleagues, including Christopher B. Fox and Steven G. Reed. These collaborations have further enriched her research and have led to significant advancements in the field.
Conclusion
Susan Baldwin's innovative work in the development of adjuvant formulations has made a substantial impact on immunology. Her contributions continue to influence the field and pave the way for future advancements in vaccine development.